Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries

Inclusion Criteria:

1. Patients treated with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis as aBridging Stent in conjunction with a branched/fenestrated stent graft to allowendovascular aneurysm repair from 31 December 2021 until 01 January 2017

2. Age ≥18 years at the time of implant

3. Provision of informed consent by the patient or next of kin/legal representative (for deceased patients at registry entry, unless a waiver was granted), according tolocal regulations.

Exclusion Criteria:

1. Patient treated for ruptured aneurysm or who were otherwise hemodynamically unstableat the time of the procedure

2. Patient treated for acute or sub-acute dissection, <90 days from onset of symptoms

3. Patient treated using physician-modified endovascular grafts

4. Patient intended to be treated with chimney, periscope, octopus, sandwich techniqueper the pre-treatment case plan

5. At the time of treatment, patient had known coagulation disorders includinghypercoagulability that were not amenable to treatment

6. Patient was pregnant at the time of treatment.

7. Participation in another drug or device investigational study within one year ofdevice implant, that can confound the registry endpoints.

8. Patient had known or suspected systemic infection (including treatment for mycoticaneurysm) at the time of implant.